NO20082848L - Farmasoytisk formulering for behandling av osteoartritt inneholdende klodronsyre og hyaluronsyre - Google Patents

Farmasoytisk formulering for behandling av osteoartritt inneholdende klodronsyre og hyaluronsyre

Info

Publication number
NO20082848L
NO20082848L NO20082848A NO20082848A NO20082848L NO 20082848 L NO20082848 L NO 20082848L NO 20082848 A NO20082848 A NO 20082848A NO 20082848 A NO20082848 A NO 20082848A NO 20082848 L NO20082848 L NO 20082848L
Authority
NO
Norway
Prior art keywords
acid
treatment
pharmaceutical formulation
hyaluronic acid
osteoarthritis containing
Prior art date
Application number
NO20082848A
Other languages
English (en)
Other versions
NO340794B1 (no
Inventor
Sergio Rosini
Silvia Trasciatti
Original Assignee
Abiogen Pharma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abiogen Pharma Spa filed Critical Abiogen Pharma Spa
Publication of NO20082848L publication Critical patent/NO20082848L/no
Publication of NO340794B1 publication Critical patent/NO340794B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm rests
    • A61M5/178—Syringes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)

Abstract

Farmasøytiske blandinger som inneholder klodronsyre og hyaluronsyre eller deres salter som aktive innholdsstoffer, blandet med passende formidlere, blir beskrevet.
NO20082848A 2005-12-29 2008-06-26 Farmasøytisk formulering for behandling av osteoartritt inneholdende klodronsyre og hyaluronsyre NO340794B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT002515A ITMI20052515A1 (it) 2005-12-29 2005-12-29 Formulazione farmaceutica per il trattamento della osteoartrite
PCT/EP2006/012367 WO2007073921A1 (en) 2005-12-29 2006-12-21 Pharmaceutical formulation for the treatment of osteoarthritis containing clodronic acid and hyaluronic acid

Publications (2)

Publication Number Publication Date
NO20082848L true NO20082848L (no) 2008-08-27
NO340794B1 NO340794B1 (no) 2017-06-19

Family

ID=36648609

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20082848A NO340794B1 (no) 2005-12-29 2008-06-26 Farmasøytisk formulering for behandling av osteoartritt inneholdende klodronsyre og hyaluronsyre

Country Status (20)

Country Link
US (4) US20090042833A1 (no)
EP (1) EP1976538B1 (no)
JP (1) JP2009522218A (no)
KR (2) KR101470608B1 (no)
AT (1) ATE446763T1 (no)
AU (1) AU2006331019B2 (no)
CA (1) CA2646974C (no)
CY (1) CY1109541T1 (no)
DE (1) DE602006010111D1 (no)
DK (1) DK1976538T3 (no)
ES (1) ES2333615T3 (no)
IT (1) ITMI20052515A1 (no)
NO (1) NO340794B1 (no)
NZ (1) NZ569420A (no)
PL (1) PL1976538T3 (no)
PT (1) PT1976538E (no)
RU (1) RU2414908C2 (no)
SI (1) SI1976538T1 (no)
WO (1) WO2007073921A1 (no)
ZA (1) ZA200805598B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103260628B (zh) * 2010-10-07 2015-07-29 成功大学 透明质酸用于促进血管生成的用途
CN111773173B (zh) 2014-11-07 2024-03-22 胞外体干细胞株式会社 用于成脂分化诱导、脂肪组织再生、皮肤美白或改善皱纹的包含干细胞来源外泌体的组合物
KR101706642B1 (ko) 2015-02-04 2017-02-17 주식회사 엑소스템텍 연골세포로 분화되고 있는 줄기세포로부터 추출된 엑소좀을 포함하는 연골세포 분화 유도 또는 연골조직 재생용 조성물
IT201600123773A1 (it) * 2016-12-06 2018-06-06 Abiogen Pharma Spa Composizione per il trattamento dell’osteoartrosi
IT202100023894A1 (it) * 2021-09-16 2023-03-16 Professional Derma Sa Composizione per utilizzo in campo ortopedico
JP2024113337A (ja) * 2023-02-09 2024-08-22 国立大学法人九州大学 変形性関節症治療用医薬組成物及びキット
EP4450062A1 (en) * 2023-04-20 2024-10-23 Abiogen Pharma S.p.A. Composition for the treatment of osteoarthrosis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1187828B (it) * 1985-05-24 1987-12-23 Gentili Ist Spa Composizione farmaceutica a base di difosfonati per il trattamento dell aretrosi
JP2001253827A (ja) * 2000-02-15 2001-09-18 Pfizer Prod Inc 骨粗鬆症を治療するための組成物および方法
KR100492110B1 (ko) * 2000-05-05 2005-06-02 에프. 호프만-라 로슈 아게 비스포스폰산 또는 그의 염을 포함하는 피하 투여용겔-유사 약학 조성물
WO2003099992A2 (en) * 2002-05-17 2003-12-04 Wyeth Injectable solid hyaluronic acid carriers for delivery of osteogenic proteins
KR100648515B1 (ko) * 2004-05-04 2006-11-27 (주)아모레퍼시픽 비스포스포네이트-함유 고분자 미립구를 포함하는 골-관련질환 치료 또는 예방용 서방 효과를 갖는 주사제

Also Published As

Publication number Publication date
SI1976538T1 (sl) 2010-01-29
KR20080082657A (ko) 2008-09-11
US9943540B2 (en) 2018-04-17
US20090042833A1 (en) 2009-02-12
CA2646974A1 (en) 2007-07-05
ATE446763T1 (de) 2009-11-15
EP1976538B1 (en) 2009-10-28
RU2414908C2 (ru) 2011-03-27
ZA200805598B (en) 2009-11-25
EP1976538A1 (en) 2008-10-08
AU2006331019B2 (en) 2012-03-22
HK1123986A1 (en) 2009-07-03
ITMI20052515A1 (it) 2007-06-30
ES2333615T3 (es) 2010-02-24
PT1976538E (pt) 2009-12-07
PL1976538T3 (pl) 2010-03-31
CY1109541T1 (el) 2014-08-13
RU2008126108A (ru) 2010-01-10
JP2009522218A (ja) 2009-06-11
DE602006010111D1 (de) 2009-12-10
WO2007073921A1 (en) 2007-07-05
CA2646974C (en) 2013-06-11
DK1976538T3 (da) 2010-01-11
US20180185407A1 (en) 2018-07-05
AU2006331019A1 (en) 2007-07-05
US20200147126A1 (en) 2020-05-14
NZ569420A (en) 2010-05-28
KR20140107651A (ko) 2014-09-04
AU2006331019A2 (en) 2009-01-22
KR101470608B1 (ko) 2014-12-09
NO340794B1 (no) 2017-06-19
US20140371170A1 (en) 2014-12-18

Similar Documents

Publication Publication Date Title
ATE470443T1 (de) Indol-1-yl-essigsäurederivate
EA201170772A1 (ru) Органические соединения
WO2006086562A3 (en) Phenylazetidinone derivatives
UY31673A1 (es) "derivados heterocíclicos de urea y métodos de uso de los mismos-211"
MY149957A (en) Heterocyclic inhibitors of mek and methods of use thereof
EA200900155A1 (ru) Модуляторы фармакокинетических свойств лекарственных средств
MY143795A (en) Tetrahydropyridoindole derivatives
CY1112889T1 (el) Αναλογα αζετιδινης αναστολεων νουκλεοσιδασης και φωσφορυλασης
BR122020010667B8 (pt) inibidores de quinase, seus usos, e composição farmacêutica
CY1110813T1 (el) Χημικες ενωσεις
WO2009135190A3 (en) Therapeutic calcium phosphate particles and methods of making and using same
WO2009109927A3 (en) Glp-1 receptor agonists and related active pharmaceutical ingredients for treatment of cancer
MY166653A (en) Derivatives of 1-amino-2-cyclobutylethylboronic acid
NO20090348L (no) Substituerte imidazolonderivater, sammensetninger og anvendelser av samme, samt fremgangsmater for fremstilling av samme
DE502004002571D1 (de) Substituierte 3-pyrrolidin-indol-derivate
CL2007001710A1 (es) Compuestos derivados de amino-pirazolopiridina sustituidos; metodo de preparacion; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como tumores, artritis reumatoide, enfermedades de crecimiento vascular desregulado, entre otras.
TR200806298A2 (tr) Farmasötik formülasyon
EA200900267A1 (ru) КОМПОЗИЦИЯ ДЛЯ АЭРОЗОЛЬНОЙ ИНГАЛЯЦИИ β-АГОНИСТОВ И СТЕРОИДОВ
DE60313004D1 (de) Alpha-7-nikotinsäure-rezeptoragonisten und statine in kombination
TW200738659A (en) Novel compounds
CY1109541T1 (el) Φαρμακευτικη συνταγοποιηση για την θεραπεια οστεοαρθριτιδας η οποια περιεχει κλοδρονικο οξυ και υαλουρονικο οξυ
GEP20156346B (en) Imidazole derivatives as pde10a enzyme inhibitors
UA91848C2 (ru) Применение соединений диосметина в лечении и предотвращении тромботическим патологиям
SE0301320D0 (sv) Positive modulators of nicotinic acetylcholine receptors
DE502006004182D1 (de) Substituierte 5,6,7,8-tetrahydro-imidazoä1 ,2-aüpyridin-2-ylamin-verbindungen und deren verwendung zur herstellung von arzneimitteln